Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00772200 · ClinicalTrials.gov registry record

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

A clinical trial of Childhood Malignant Neoplasm, sponsored by Children's Oncology Group.

Active
Registry status
1,200
Enrollment target
20
Study locations

NCT00772200: Active study of Childhood Malignant Neoplasm, sponsored by Children's Oncology Group.

NCT00772200 is a study of Childhood Malignant Neoplasm that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 1,200 participants. The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00772200, a study of Childhood Malignant Neoplasm, is active but no longer recruiting, sponsored by Children's Oncology Group.

ACTIVE NOT RECRUITING
Registry status
1,200 participants
Enrollment target
20
Study locations

Study Summary

This research trial studies neuropsychological (learning, remembering or thinking) and behavioral outcomes in children and adolescents with cancer by collecting information over time from a series of tests.

Interventions

  • OTHER Quality-of-Life Assessment
  • PROCEDURE Cognitive Assessment

Study Locations (20)

California

  • Kaiser Permanente Downey Medical Center - Downey
  • Miller Children's and Women's Hospital Long Beach - Long Beach
  • Children's Hospital Los Angeles - Los Angeles
  • Cedars Sinai Medical Center - Los Angeles
  • Mattel Children's Hospital UCLA - Los Angeles
  • Valley Children's Hospital - Madera
  • Children's Hospital and Research Center at Oakland - Oakland
  • Kaiser Permanente-Oakland - Oakland
  • Children's Hospital of Orange County - Orange
  • Lucile Packard Children's Hospital Stanford University - Palo Alto
  • Rady Children's Hospital - San Diego - San Diego
  • UCSF Medical Center-Parnassus - San Francisco
  • UCSF Medical Center-Mission Bay - San Francisco
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center - Torrance

Alabama

  • Children's Hospital of Alabama - Birmingham
  • University of Alabama at Birmingham Cancer Center - Birmingham

Arizona

  • Cardon Children's Medical Center - Mesa
  • Phoenix Childrens Hospital - Phoenix

Colorado

  • Children's Hospital Colorado - Aurora

Connecticut

  • Connecticut Children's Medical Center - Hartford

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2009-02-27
Children's Oncology Group

342 total trials

What the registry record for NCT00772200 still lists

NCT00772200 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Childhood Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.

NCT00772200 names 20 study sites across 5 states, led by California, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT00772200 about?

NCT00772200 is a clinical study titled "Neuropsychological and Behavioral Testing in Younger Patients With Cancer". This research trial studies neuropsychological (learning, remembering or thinking) and behavioral outcomes in children and adolescents with cancer by collecting information over time from a series of tests.

What is the current status of trial NCT00772200?

This trial is currently active not recruiting. The enrollment target is 1,200 participants. The study started on 2009-02-27.

What conditions does trial NCT00772200 study?

This clinical trial studies the following conditions: Childhood Malignant Neoplasm.

What interventions are being tested in trial NCT00772200?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Cognitive Assessment (PROCEDURE).

Who is sponsoring clinical trial NCT00772200?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00772200 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00772200, the US trial registry maintained by the National Library of Medicine. NCT00772200 (large enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.